Nevertheless, tumours often develop resistance to radiotherapy, and paradoxically, recent work has shown that elevated tumoural expression of a subset of IFN-stimulated genes (ISGs) known as the IFN-related DNA damage resistance signature (IRDS) positively correlates with therapy resistance across multiple cancer types [1,6]. This evidence concerns the gene IFNA1 and cancer.